Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 23, 2017

DrugPatentWatch Database Preview

APTIVUS Drug Profile

« Back to Dashboard

Which patents cover Aptivus, and when can generics launch?

Aptivus is a drug marketed by Boehringer Ingelheim and is included in two NDAs. There are three patents protecting this drug.

This drug has one hundred and forty-eight patent family members in thirty-one countries.

The generic ingredient in APTIVUS is tipranavir. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the tipranavir profile page.

Summary for Tradename: APTIVUS

Suppliers / Packagers: see list1
Bulk Api Vendors: see list27
Clinical Trials: see list2
Patent Applications: see list2,702
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:APTIVUS at DailyMed

Pharmacology for Tradename: APTIVUS

Drug ClassProtease Inhibitor
Mechanism of ActionHIV Protease Inhibitors
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim
CAPSULE;ORAL021814-001Jun 22, 2005RXYesYes5,852,195*PED► SubscribeY► Subscribe
Boehringer Ingelheim
SOLUTION;ORAL022292-001Jun 23, 2008RXYesYes5,852,195*PED► SubscribeY► Subscribe
Boehringer Ingelheim
CAPSULE;ORAL021814-001Jun 22, 2005RXYesYes6,147,095*PED► SubscribeY► Subscribe
Boehringer Ingelheim
CAPSULE;ORAL021814-001Jun 22, 2005RXYesYes6,231,887*PED► SubscribeY► Subscribe
Boehringer Ingelheim
SOLUTION;ORAL022292-001Jun 23, 2008RXYesYes6,147,095*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus